A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)
Clinical trial NCT04498247 · TERMINATED
Trial details
- NCT number
- NCT04498247
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2021-03-05
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.